Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: a case report

亚阈值微脉冲激光治疗伴有脉络膜血管瘤的中心性浆液性脉络膜视网膜病变的疗效和安全性:病例报告

阅读:1

Abstract

BACKGROUND: Circumscribed choroidal hemangioma (CCH) is a benign vascular hamartoma caused by congenital vascular malformation. And, central serous chorioretinopathy (CSCR) is a chorioretinal disease characterized by pachychoroid, RPE irregularities, and subretinal fluid (SRF) accumulation. Some literature has indicated a potential correlation between the occurrences of CCH and CSCR. CASE PRESENTATION: A 59-year-old man presented with blurred vision in his right eye for six months, with an unremarkable history. Multimodal imaging techniques including color fundus photography, fundus autofluorescence (FAF), B-scan ultrasonography (USG), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT), revealed the presence of CCH accompanying CSCR in the right eye. The patient received treatment with SML for CSCR, while no specific treatment was administered for CCH. The SRF was fully resolved one month after the treatment. At the 3- and 6-month follow-up, SRF resolved, and best-corrected visual acuity (BCVA) improved from 0.6 to 0.9 in the decimal format in the right eye, without notable changes in subfoveal choroidal thickness (SFCT) or the size of CCH. CONCLUSION: This case reported the coexistence of CCH and CSCR in the right eye, both characterized by choroidal vascular abnormalities. Further research is necessary to determine the favorable effect of SML in patients with CSCR and concurrent CCH.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。